BioPlus participated in CMEF Qingdao 2019, China for four days from October 19 to 22, 2019.
This exhibition is mainly focused on medical devices, and BioPlus promoted InterBlock, SynoFil and hyaluronic acid filler in particular.
Bioplus is steadily promoting its products not only in China, but also in Southeast Asia, including Thailand and Malaysia. In addition, not only the hyaluronic acid beauty products, but also the other...
Bioplus participated in the Cosmobeauty Indonesian Cosmetics & Beauty Fair from October 17 to 19.
This exhibition is Indonesia's largest international beauty fair and it serves as a bridgehead for entering the highly potential beauty market in Indonesia, which boasts the world's fourth largest population.
This exhibition has a total exhibition area of 11,000 square meters, 328 companies from 13 countries participated as exhibi...
Bioplus participated in the 3rd Korea-Bahrain Business Forum, which was hosted by the Embassy of Ambassador to the Bahrain.
Bahrain is called the gateway to the Middle East because of its conditions as an outpost for Saudi Arabia's largest market. In particular, the 3rd Korea-Bahrain Business Forum was a big event with diverse industries including medical devices, pharmaceuticals, logistics, beauty, health, food, st...
Bioplus participated in the 2019 Columbia Beauty & Health Exhibition for a three-day run from October 2 to 4.
The exhibition will be held at the Bogota International Business and Exposition Center and will be attended by 452 companies, 80 countries and 68,400 people as of 2017. The exhibition will consist of items such as skin care, beauty & spas, hair & nail, wellness & fitness, etc.
Bioplus participated in the 2019 Intercharm UKRAIN held in Kiev, Ukraine, for three days from September 18, 199.
Ukraine, a newly emerging and emerging leading market, has seen more than 100 percent growth in the plastic surgery and beauty market every year, and is even more anticipated because Korean companies have not yet entered the market.
This exhibition is the largest beauty fair in Ukraine and has the scale and recognit...
BioPlus Co., Ltd. received permission to manufacture veterinary medical devices from the Animal Drug Management Division on July 18, 2019. In addition, the approval of the 'Dressing, deep- cavity wound (adhesion inhibitor)' for animals was completed.
In Korea, the number of pets is increasing due to the increase of single-person households and the aging population, and the market size is growing every year.
BioPlus participated in C-Medical Fair, one of China's largest medical device exhibition in Shanghai, from July 11-13, 2019.
‘The C-Medical Fair covers comprehensive products, including medical electronic products, medical imaging equipment, ward nursing and auxiliary equipment,medical supplies and hygienic materials, testing equipment and diagnostic reagents, optical products, first aid products, rehabilitation nursing product...
BioPlus Co., Ltd., a manufacturer specializing in fillers, obtained the Medical Device Single Screening Program (MDSAP) certification on 23 June.
The Medical Device Single Audit Program (MDSAP) is a system that certifies medical devices that meet the criteria requirements through a single review at the International Medical Device Regulatory Forum (IMDRF) for medical device safety and quality control.